Biomarkers of LONG COVID (LONG COVID

Biomarkers of LONG COVID (LONG COVID_LCM)

Conditions: Long COVID

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: 1

Enrollment: 100

Sponsor: IRCCS Policlinico S. Donato

Location: Italy

Summary

This observational prospective study is aimed to investigate noncoding RNAs (ncRNAs) such as microRNAs (miRNAs) and long noncoding RNAs (lncRNAs) as potential peripheral blood biomarkers of severity and poor prognosis in COVID-19 patients. Patients with intermittent or permanent symptoms after COVID-19 at the moment of the recruitment were considered affected by LONG COVID disease. In particular, the aim is to clarify if COVID-19 biomarkers remain deregulated similarly in LONG COVID patients. To this purpose, plasma and peripheral blood mononuclear cells (PBMCs) will be collected and patients will be compared to individuals who have never been affected by COVID-19 or asymptomatic LONG COVID patients.

Eligibility Criteria

Inclusion Criteria:Previous COVID-19 infectionExclusion Criteria:-

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05672602). StuddyBuddy aggregates publicly available trial information.